BACKGROUND AND PURPOSE: This American Heart Association (AHA) scientific statement provides a comprehensive overview of current evidence on the burden cardiovascular disease (CVD) among Hispanics in the United States. Hispanics are the largest minority ethnic group in the United States, and their health is vital to the public health of the nation and to achieving the AHA's 2020 goals. This statement describes the CVD epidemiology and related personal beliefs and the social and health issues of US Hispanics, and it identifies potential prevention and treatment opportunities. The intended audience for this statement includes healthcare professionals, researchers, and policy makers. METHODS: Writing group members were nominated by the AHA's Manuscript Oversight Committee and represent a broad range of expertise in relation to Hispanic individuals and CVD. The writers used a general framework outlined by the committee chair to produce a comprehensive literature review that summarizes existing evidence, indicate gaps in current knowledge, and formulate recommendations. Only English-language studies were reviewed, with PubMed/MEDLINE as our primary resource, as well as the Cochrane Library Reviews, Centers for Disease Control and Prevention, and the US Census data as secondary resources. Inductive methods and descriptive studies that focused on CVD outcomes incidence, prevalence, treatment response, and risks were included. Because of the wide scope of these topics, members of the writing committee were responsible for drafting individual sections selected by the chair of the writing committee, and the group chair assembled the complete statement. The conclusions of this statement are the views of the authors and do not necessarily represent the official view of the AHA. All members of the writing group had the opportunity to comment on the initial drafts and approved the final version of this document. The manuscript underwent extensive AHA internal peer review before consideration and approval by the AHA Science Advisory and Coordinating Committee. RESULTS: This statement documents the status of knowledge regarding CVD among Hispanics and the sociocultural issues that impact all subgroups of Hispanics with regard to cardiovascular health. In this review, whenever possible, we identify the specific Hispanic subgroups examined to avoid generalizations. We identify specific areas for which current evidence was less robust, as well as inconsistencies and evidence gaps that inform the need for further rigorous and interdisciplinary approaches to increase our understanding of the US Hispanic population and its potential impact on the public health and cardiovascular health of the total US population. We provide recommendations specific to the 9 domains outlined by the chair to support the development of these culturally tailored and targeted approaches. CONCLUSIONS: Healthcare professionals and researchers need to consider the impact of culture and ethnicity on health behavior and ultimately health outcomes. There is a need to tailor and develop culturally relevant strategies to engage Hispanics in cardiovascular health promotion and cultivate a larger workforce of healthcare providers, researchers, and allies with the focused goal of improving cardiovascular health and reducing CVD among the US Hispanic population.
BACKGROUND AND PURPOSE: This American Heart Association (AHA) scientific statement provides a comprehensive overview of current evidence on the burden cardiovascular disease (CVD) among Hispanics in the United States. Hispanics are the largest minority ethnic group in the United States, and their health is vital to the public health of the nation and to achieving the AHA's 2020 goals. This statement describes the CVD epidemiology and related personal beliefs and the social and health issues of US Hispanics, and it identifies potential prevention and treatment opportunities. The intended audience for this statement includes healthcare professionals, researchers, and policy makers. METHODS: Writing group members were nominated by the AHA's Manuscript Oversight Committee and represent a broad range of expertise in relation to Hispanic individuals and CVD. The writers used a general framework outlined by the committee chair to produce a comprehensive literature review that summarizes existing evidence, indicate gaps in current knowledge, and formulate recommendations. Only English-language studies were reviewed, with PubMed/MEDLINE as our primary resource, as well as the Cochrane Library Reviews, Centers for Disease Control and Prevention, and the US Census data as secondary resources. Inductive methods and descriptive studies that focused on CVD outcomes incidence, prevalence, treatment response, and risks were included. Because of the wide scope of these topics, members of the writing committee were responsible for drafting individual sections selected by the chair of the writing committee, and the group chair assembled the complete statement. The conclusions of this statement are the views of the authors and do not necessarily represent the official view of the AHA. All members of the writing group had the opportunity to comment on the initial drafts and approved the final version of this document. The manuscript underwent extensive AHA internal peer review before consideration and approval by the AHA Science Advisory and Coordinating Committee. RESULTS: This statement documents the status of knowledge regarding CVD among Hispanics and the sociocultural issues that impact all subgroups of Hispanics with regard to cardiovascular health. In this review, whenever possible, we identify the specific Hispanic subgroups examined to avoid generalizations. We identify specific areas for which current evidence was less robust, as well as inconsistencies and evidence gaps that inform the need for further rigorous and interdisciplinary approaches to increase our understanding of the US Hispanic population and its potential impact on the public health and cardiovascular health of the total US population. We provide recommendations specific to the 9 domains outlined by the chair to support the development of these culturally tailored and targeted approaches. CONCLUSIONS: Healthcare professionals and researchers need to consider the impact of culture and ethnicity on health behavior and ultimately health outcomes. There is a need to tailor and develop culturally relevant strategies to engage Hispanics in cardiovascular health promotion and cultivate a larger workforce of healthcare providers, researchers, and allies with the focused goal of improving cardiovascular health and reducing CVD among the US Hispanic population.
Authors: Cynthia L Ogden; Margaret D Carroll; Lester R Curtin; Margaret A McDowell; Carolyn J Tabak; Katherine M Flegal Journal: JAMA Date: 2006-04-05 Impact factor: 56.272
Authors: Paul D Sorlie; Larissa M Avilés-Santa; Sylvia Wassertheil-Smoller; Robert C Kaplan; Martha L Daviglus; Aida L Giachello; Neil Schneiderman; Leopoldo Raij; Gregory Talavera; Matthew Allison; Lisa Lavange; Lloyd E Chambless; Gerardo Heiss Journal: Ann Epidemiol Date: 2010-08 Impact factor: 3.797
Authors: Carol A Derby; Rachel P Wildman; Aileen P McGinn; Robin R Green; Alex J Polotsky; Kavitha T Ram; Janice Barnhart; Gerson Weiss; Nanette Santoro Journal: Ethn Dis Date: 2010 Impact factor: 1.847
Authors: Robert Detrano; Alan D Guerci; J Jeffrey Carr; Diane E Bild; Gregory Burke; Aaron R Folsom; Kiang Liu; Steven Shea; Moyses Szklo; David A Bluemke; Daniel H O'Leary; Russell Tracy; Karol Watson; Nathan D Wong; Richard A Kronmal Journal: N Engl J Med Date: 2008-03-27 Impact factor: 91.245
Authors: Matthew P Conomos; Cecelia A Laurie; Adrienne M Stilp; Stephanie M Gogarten; Caitlin P McHugh; Sarah C Nelson; Tamar Sofer; Lindsay Fernández-Rhodes; Anne E Justice; Mariaelisa Graff; Kristin L Young; Amanda A Seyerle; Christy L Avery; Kent D Taylor; Jerome I Rotter; Gregory A Talavera; Martha L Daviglus; Sylvia Wassertheil-Smoller; Neil Schneiderman; Gerardo Heiss; Robert C Kaplan; Nora Franceschini; Alex P Reiner; John R Shaffer; R Graham Barr; Kathleen F Kerr; Sharon R Browning; Brian L Browning; Bruce S Weir; M Larissa Avilés-Santa; George J Papanicolaou; Thomas Lumley; Adam A Szpiro; Kari E North; Ken Rice; Timothy A Thornton; Cathy C Laurie Journal: Am J Hum Genet Date: 2016-01-07 Impact factor: 11.025
Authors: Jia Pu; Robert Romanelli; Beinan Zhao; Kristen M J Azar; Katherine G Hastings; Vani Nimbal; Stephen P Fortmann; Latha P Palaniappan Journal: Cardiol Clin Date: 2015-05 Impact factor: 2.213
Authors: Kelly R Evenson; Elva M Arredondo; Mercedes R Carnethon; Alan M Delamater; Linda C Gallo; Carmen R Isasi; Krista M Perreira; Samantha A Foti; Linda VAN Horn; Denise C Vidot; Daniela Sotres-Alvarez Journal: Med Sci Sports Exerc Date: 2019-05 Impact factor: 5.411
Authors: Qibin Qi; Stephanie M Gogarten; Leslie S Emery; Tin Louie; Adrienne Stilp; Jianwen Cai; Neil Schneiderman; M Larissa Avilés-Santa; Robert C Kaplan; Kari E North; Cathy C Laurie; Ruth J F Loos; Carmen R Isasi Journal: Obesity (Silver Spring) Date: 2016-09-24 Impact factor: 5.002
Authors: Tali Elfassy; Daniela Sotres-Alvarez; Linda Van Horn; Sonia Angell; Neil Schneiderman; Tatjana Rundek; Leopoldo Raij; Sylvia W Smoller; Yasmin Mossavar-Rahmani; Martha L Daviglus; David B Hanna; Adina Zeki Al Hazzouri Journal: Am J Hypertens Date: 2019-08-14 Impact factor: 2.689
Authors: David B Hanna; Shuo Xu; Michal L Melamed; Franklyn Gonzalez; Matthew A Allison; Martin S Bilsker; Barry E Hurwitz; Mayank M Kansal; Neil Schneiderman; Sanjiv J Shah; Robert C Kaplan; Carlos J Rodriguez; Jorge R Kizer Journal: Am J Cardiol Date: 2017-03-29 Impact factor: 2.778
Authors: Guo-Chong Chen; Jin Choul Chai; Bing Yu; Gregory A Michelotti; Megan L Grove; Amanda M Fretts; Martha L Daviglus; Olga L Garcia-Bedoya; Bharat Thyagarajan; Neil Schneiderman; Jianwen Cai; Robert C Kaplan; Eric Boerwinkle; Qibin Qi Journal: Am J Clin Nutr Date: 2020-07-01 Impact factor: 7.045
Authors: Arleen F Brown; Li-Jung Liang; Stefanie D Vassar; Jose J Escarce; Sharon Stein Merkin; Eric Cheng; Adam Richards; Teresa Seeman; W T Longstreth Journal: Ann Intern Med Date: 2018-03-20 Impact factor: 25.391